TUESDAY, March 19, 2019 (HealthDay News) — Nutra Pharma Corp. has been warned about illegal marketing of unapproved homeopathic products with claims that they can treat addiction and chronic pain from serious conditions such as cancer, diabetes, shingles, and fibromyalgia, the U.S. Food and Drug Administration says.
A warning letter was issued to the company for the products Nyloxin Oral Spray, Nyloxin Topical Gel, Nyloxin Topical Roll-On, Nyloxin Topical Roll-On ES, Nyloxin Professional Size Pump Topical Gel, and Regular Strength Sample Pack. The names of the products may also confuse consumers because they are similar to the names of FDA-approved products, the agency said.
The FDA asked Nutra Pharma to respond within 15 working days and warned that failure to correct the violations may result in legal action such as seizure and injunction.
“Health fraud scams like these are inexcusable. These patients deserve proven treatments not false promises that can deter them from seeking otherwise effective care, and that can also contain ingredients or contaminations that can threaten their health,” FDA Commissioner Scott Gottlieb, M.D., said in an agency news release. “We have great concern for the millions of Americans who live with chronic pain or cancer, and for whom traditional treatment options have been exhausted, as well as those battling opioid addiction.”
Copyright © 2019 HealthDay. All rights reserved.
